As we near the end of 2022, we thought we would share some of our most popular blog posts of the past year with you. We’ve talked about a huge number of subjects this year, but these ones were your favourites!
3. Opening of the Charlton Digestive Disease Centre
2. Health Canada Approves Three New Adalimumab Biosimilars
We want to hear from you! Is there a blog topic that you haven’t seen us write about yet? Let us know what you would like to learn about in 2023 by sending us an email!
Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…
Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…
Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…
Every year on October 12, World Arthritis Day raises awareness about the millions of people…
Tremfya (guselkumab) has been available for several years to treat plaque psoriasis and psoriatic arthritis.…
This week, many will return to school, and it's no secret that the back-to-school season…